Precision medicine in action: A timely article on progress in the program and plans for recruiting a million or more participants.
A diverse, large-scale longitudinal research study to advance #PrecisionMedicine for all of us! Open access overview of the study here👇 The “All of Us” Research Program | NEJM
In , describes its aim of following 1M diverse people over decades to improve how we prevent & treat disease through precision medicine. Check it out and #JoinAllofUs #NIH
Every day we're working to build one of the largest, most diverse health databases of its kind to help advance research and #precisionmedicine. Read about our progress + plans for the future in the All of Us special report in : #JoinAllofUs
Fantastic to see that CPIC guidelines will be used to report #pharmacogenomic results back to participants. Thank you to all of our guideline authors for your hard work! #PGx #PrecisionMedicine
Looks like an interesting data collection effort; "80% of these [175,000] participants are from groups that have been historically underrepresented in biomedical research."
This week the program paper was published #openaccess More than half of the participants are from under-represented minorities.
Impressive enrollment/commitment to diversity for All of Us but my big question is: Was the tech piece of this successful in driving engagement? What was the engagement? And was it better/worse than more analog, longitudinal studies
The “All of Us” Research Program
Congratulations to program for their feature in . The progress for this study is phenomenal – over 80% of data is from underrepresented groups in research. Proud to have worked to get this program off the ground.
The “All of Us” Research Program | NEJM
Examples of biobanks: BioBank Graz, ~20 million human derived samples; biobank ~500 000 participants (genotypes & extensive phenotype); All of Us (target: 1 million participants); China Kadoorie Biobank (510 000 participants).
The “All of Us” Research Program | NEJM
The “All of Us” Research Program | NEJM